LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 34.50 | 770.25 | 2032 | 3712 | 0.5474 | 0.5335 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 34.50 | 770.25 | 2231 | 3712 | 0.6010 | 0.5980 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 36.73 | 770.25 | 2165 | 4086 | 0.5298 | 0.5362 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 36.73 | 770.25 | 2363 | 4086 | 0.5783 | 0.5931 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 38.95 | 770.25 | 2260 | 4543 | 0.4974 | 0.5226 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 38.95 | 770.25 | 2520 | 4543 | 0.5546 | 0.5887 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.17 | 770.25 | 2415 | 5010 | 0.4820 | 0.5265 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.17 | 770.25 | 2666 | 5010 | 0.5321 | 0.5834 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.39 | 770.25 | 2522 | 5404 | 0.4667 | 0.5250 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.39 | 770.25 | 2799 | 5404 | 0.5179 | 0.5826 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.61 | 770.25 | 2684 | 5813 | 0.4617 | 0.5344 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.61 | 770.25 | 3018 | 5813 | 0.5192 | 0.5974 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.83 | 770.25 | 2844 | 6223 | 0.4570 | 0.5424 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 47.83 | 770.25 | 3194 | 6223 | 0.5132 | 0.6030 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.05 | 770.25 | 3006 | 6629 | 0.4534 | 0.5503 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.05 | 770.25 | 3391 | 6629 | 0.5115 | 0.6117 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.27 | 770.25 | 3169 | 7058 | 0.4489 | 0.5567 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 52.27 | 770.25 | 3625 | 7058 | 0.5135 | 0.6236 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.49 | 770.25 | 3324 | 7555 | 0.4399 | 0.5588 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 54.49 | 770.25 | 3793 | 7555 | 0.5020 | 0.6225 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.71 | 770.25 | 3519 | 8001 | 0.4398 | 0.5681 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.71 | 770.25 | 4035 | 8001 | 0.5043 | 0.6330 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.94 | 770.25 | 3686 | 8444 | 0.4365 | 0.5733 | MN20160304_L02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.94 | 770.25 | 4202 | 8444 | 0.4976 | 0.6341 | MN20160304_L02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 61.16 | 770.25 | 3931 | 8892 | 0.4421 | 0.5870 | MN20160304_L02 | L07 |